CT CELLENGENE CELL AND GENE THERAPY

Pharmaceutical preparations for treating diabetes; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of cells; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; stem cells for medical purposes; antidiabetic preparations; anti-diabetic pharmaceuticals; anti-cancer preparations

Development of cell therapy products, namely, research and development and consultation related thereto in the field of cell engineering technology; scientific research for medical purposes in the area of cancerous diseases; research services relating to pharmaceuticals, namely, stem cell research services; stem cell research services

Medical services in the field of diabetes; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; health care services for treating cancer; medical services relating to the removal, treatment and processing of human cells; medical analysis relating to clinical data, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories